Yoshinori Aoki

Dr. Yoshinori Aoki

Pediatrics, University of Miyazaki, Miyazaki, Japan
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2026 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
YAYoshinori Aoki
Yoshinori Aoki
MTMayumi Tate
Mayumi Tate
KOKayo Ochiai
Kayo Ochiai
KTKohei Tsuchimochi
Kohei Tsuchimochi
UMUiko Mizuguchi
Uiko Mizuguchi
HMHiroshi Moritake
Hiroshi Moritake
Early empirical antibiotic therapy is common in preterm and very low birth weight (VLBW) infants but may disrupt the developing gut microbiome. However, the effects of brief antibiotic courses remain unclear, particularly in the most immature infants. In this prospective multicenter cohort study, we examined gut microbiome trajectories in VLBW infants (many of whom were extremely preterm) receiving no antibiotics, a short course (≤2 days), or prolonged exposure (≥3 days). Serial stool samples were analyzed using 16S rRNA gene sequencing. Microbiome composition and diversity in the short-course group were similar to those in unexposed infants at all timepoints, indicating that brief antibiotic exposure did not disrupt microbial development. In contrast, prolonged exposure was associated with transient dysbiosis characterized by reduced Bifidobacterium abundance and lower alpha diversity, with partial recovery by discharge. These findings suggest that limiting empirical antibiotic therapy to ≤2 days (48 h) when infection is unconfirmed may not disrupt microbiome development even in highly immature preterm VLBW infants, supporting evidence-based antibiotic stewardship in neonatal intensive care.

14 July 2026 in Medical Sciences
Verified
Journal Article
Open access
PDF file
TOTakuya Oshima
Takuya Oshima
YAYoshinori Aoki
Yoshinori Aoki
TATomohisa Akamatsu
Tomohisa Akamatsu
YMYutaka Matsuyama
Yutaka Matsuyama
NTNaoto Takahashi
Naoto Takahashi
MIMasayuki Itoh
Masayuki Itoh
Background/Objectives: Neonatal hypoxic–ischemic encephalopathy (HIE) is a major cause of neurodevelopmental diseases. In a previous retrospective study, we revealed that the levels of the soluble form of lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) are linked to HIE severity. We conducted a prospective investigation to evaluate the association between sLOX-1 levels and HIE severity using the Sarnat staging system, as well as a multicenter study to assess neurodevelopmental sequelae in the short term. Methods: A total of 193 infants were enrolled in the study between April 2018 and March 2021. We divided the infants into groups as follows: infants without HIE were assigned to a normal control group, and those with HIE to mild, moderate, and severe HIE groups. We measured 191 samples, excluding three participants. The distribution of 191 participants was as follows: 88 normal samples of 50 umbilical cord (UC) arteries and 38 venous blood samples (control; CTL), as well as 103 HIE samples of 34 mild, 55 moderate, and 14 severe HIE samples. All the plasma samples were collected until 6 h after birth. Results: The mean sLOX-1 value in the CTL group was 613 pg/mL (IQR: 474–925 pg/mL) and that in the UC group was 497 pg/mL (IQR: 337–693 pg/mL), with no significant difference (p = 0.136). The mean sLOX-1 value in the mild HIE group was 1030 pg/mL (IQR: 658–1547 pg/mL), 1026 pg/mL (IQR: 710–2051 pg/mL) in the moderate HIE group, and 1444 pg/mL (IQR: 766–3927 pg/mL) in the severe HIE group. There were significant differences between the CTL and HIE groups (p = 0.006) and between the CTL and mild HIE groups (p < 0.05), but not between the mild HIE and the moderate and severe HIE groups (p = 0.088). The other blood markers exhibited no correlation with Sarnat severity. Interestingly, blood sLOX-1 levels increased with Sarnat severity. Conclusions: The results of this study indicated that sLOX-1 level was correlated with Sarnat severity. Moreover, early assessment of sLOX-1 level may be useful for deciding whether to induce therapeutic hypothermia and/or other treatments, and sLOX-1 may serve as a short-term outcome biomarker of HIE.

18 July 2025 in Human Genome Variation
Verified
Journal Article
Open access
PDF file
KOKayo Ochiai
Kayo Ochiai
YAYoshinori Aoki
Yoshinori Aoki
NYNaoshi Yamada
Naoshi Yamada
MAMurasaki Aman
Murasaki Aman
AYAtsushi Yamashita
Atsushi Yamashita
HMHiroshi Moritake
Hiroshi Moritake
Tricho-hepato-enteric syndrome (THES), a rare autosomal recessive disorder caused by variants in the SKIC3 or SKIC2 gene, is characterized by intractable diarrhea, woolly hair, growth restriction and liver disease. Here we report a neonatal case of THES with neonatal hemochromatosis, in which the novel compound heterozygous SKIC3 variants NM_014639.4:c.815_816del p.(Gly272AlafsTer9) and NM_014639.4:c.2284G>A p.(Gly762Arg) were identified. Further research is needed to elucidate the mechanisms underlying iron metabolism dysregulation in THES.

1 January 2025 in Pediatrics International
Verified
Journal Article
Closed access
MTMayumi Tate
Mayumi Tate
YAYoshinori Aoki
Yoshinori Aoki
KOKayo Ochiai
Kayo Ochiai
YKYoshihiko Kodama
Yoshihiko Kodama
KNKazuhiko Nakame
Kazuhiko Nakame
HMHiroshi Moritake
Hiroshi Moritake

13 October 2026 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
YAYoshinori Aoki
Yoshinori Aoki
MNMichikazu Nakai
Michikazu Nakai
HSHirotake Sawada
Hirotake Sawada
HMHiroshi Moritake
Hiroshi Moritake

27 January 2025 in Children
Verified
Journal Article
Open access
PDF file
YAYoshinori Aoki
Yoshinori Aoki
YKYuusaku Kota
Yuusaku Kota
MSMika Shimada
Mika Shimada
TTTomoko Taniguchi
Tomoko Taniguchi
SYSaya Yamauchi
Saya Yamauchi
HMHiroshi Moritake
Hiroshi Moritake
Background: Preterm infants often have unstable vital signs and prolonged hospital stays that can hinder parent–infant bonding, especially under COVID-19 restrictions. This study aimed to evaluate whether listening to songs recorded by parents was effective in stabilizing the condition of premature infants. Methods: This randomized controlled study was conducted at the University of Miyazaki Hospital from October 2022 to March 2024 during the COVID-19 pandemic period. The participants were preterm infants born at less than 33 weeks gestation and their parents, all of whom recorded songs. The recorded songs were played daily to the infants in the intervention group, while the control group received usual care. Primary outcomes included vital signs (respiratory rate, pulse oximetry saturation, heart rate) and activity level. Results: Data for 33 preterm infants (intervention, n = 17 [total 749 sessions]; control, n = 16 [total 721 sessions]) were analyzed for changes in vital signs and activity levels. The intervention reduced infants’ respiratory rates (4.1 [95% CI: 2.5–5.6], p < 0.001) and slightly but statistically significantly increased pulse oximetry saturation (0.6 [95% CI: 0.02–1.2], p < 0.044). Conclusions: Recorded parental songs were found to safely stabilize the respiratory status of preterm infants and may serve as an accessible intervention to support parent–infant attachment, particularly in settings with restricted parental visitation.